Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;26(16):2100413.
doi: 10.2807/1560-7917.ES.2021.26.16.2100413.

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021

Collaborators, Affiliations

Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021

Sabrina Jungnick et al. Euro Surveill. 2021 Apr.

Erratum in

  • Addendum for Euro Surveill. 2021;26(16).
    Eurosurveillance editorial team. Eurosurveillance editorial team. Euro Surveill. 2021 Oct;26(43):211028a. doi: 10.2807/1560-7917.ES.2021.26.43.211028a. Euro Surveill. 2021. PMID: 34713800 Free PMC article. No abstract available.

Abstract

SARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B.1.351, generally comparable to non-VOC strain.

Keywords: B.1.1.7; B.1.351; Rapid antigen test(s); SARS-CoV-2; Variant(s) of Concern; performance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure
Figure
Reference bands for evaluation and grading of rapid antigen test results, March 2021

References

    1. Chand M, Hopkins S, Dabrera G, Achison C, Barclay W, Ferguson N, et al. Investigation of novel SARS-COV-2 variant, Variant of Concern 202012/01. [Accessed 1 Apr 2021]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
    1. World Health Organization Regional Office for Europe (WHO/Europe), European Centre for Disease Prevention and Control (ECDC). Methods for the detection and identification of SARS-CoV-2 variants. Stockholm: ECDC; Copenhagen: WHO/Europe. [Accessed 1 April 2021]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Methods-for-the...
    1. World Health Organization (WHO). SARS-CoV-2 Variants. Geneva: WHO. [Accessed 1 Apr 2021]. Available from: https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/
    1. Mautner L, Baillie C-K, Herold HM, Volkwein W, Guertler P, Eberle U, et al. Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J. 2020;17(1):160. 10.1186/s12985-020-01435-6 - DOI - PMC - PubMed
    1. Eberle U, Wimmer C, Huber I, Neubauer-Juric A, Valenza G, Ackermann N, et al. Bavarian SARS-CoV-2-Public Health Laboratory Team . Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA. Eur J Clin Microbiol Infect Dis. 2021;1-6. 10.1007/s10096-021-04159-9 - DOI - PMC - PubMed

Publication types